Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B
NCT04782375
Blood-Borne Infections, Chronic Disease
Seoul, South Korea
View Trial DetailsNCT Number: NCT01155427
The purpose of this study is to support the clinical value of entecavir by assessing the relationship between viral load and histological improvement.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Systematic review of prospective clinical trials
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bristol-Myers Squibb
Industry
A Systematic Review of Literature on Common Antiretroviral Treatments Against Hepatitis B Virus (HBV)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04782375
Blood-Borne Infections, Chronic Disease
Seoul, South Korea
View Trial DetailsNCT04749368
Blood-Borne Infections, Chronic Disease
Kingswood, New South Wales, Australia
View Trial DetailsNCT05630820
Blood-Borne Infections, Chronic Disease
Centreville, Alabama, United States
View Trial DetailsNCT05630807
Blood-Borne Infections, Chronic Disease
Chandler, Arizona, United States
View Trial Details